Intraocular pressure reduction and progression of highly myopic glaucoma: a 12-year follow-up cohort study

医学 青光眼 眼压 眼科 还原(数学) 队列研究 队列 验光服务 内科学 数学 几何学
作者
Young In Shin,Young Kook Kim,Jin Wook Jeoung,Ki Ho Park
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:: bjo-323069 被引量:2
标识
DOI:10.1136/bjo-2022-323069
摘要

Aims To investigate any association between intraocular pressure (IOP) reduction amount and open-angle glaucoma (OAG) progression in highly myopic eyes and to determine the associated risk factors. Methods One hundred and thirty-one (131) eyes of 131 patients with highly myopic OAG, all of whom had received topical medications and been followed for 5 years or longer, were enrolled. Based on the IOP reduction percentage, patients were categorised into tertile groups, and subsequently, the upper-tertile and lower-tertile groups were compared for the cumulative probability of glaucoma progression. Kaplan-Meier survival analysis and log-rank testing were applied in the comparison, and multivariate analysis with Cox’s proportional hazard model, additionally, was performed to identify progression risk factors. Results Throughout the average 11.6±4.4 year follow-up on the 131 eyes (mean age, 41.2 years at initial visit; baseline IOP, 16.4 mm Hg), 72 eyes (55.0%) showed glaucoma progression. The upper-tertile group (IOP reduction percentage>23.7%) showed a high cumulative probability of non-progression relative to the lower-tertile group (IOP reduction percentage<11.0%; p=0.034), according to the Kaplan-Meier analysis. Presence of disc haemorrhage (DH; HR=2.189; p=0.032) was determined by the multivariate Cox’s proportional hazard model to be significantly associated with glaucoma progression. For progressors, the average rate of retinal nerve fibre layer thickness thinning was −0.88±0.74 µm/year, while the MD change was −0.42±0.36 dB/year. Conclusions Glaucoma progression is associated with amount of IOP reduction by topical medications in highly myopic eyes, and DH occurrence is a glaucoma progression risk factor.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
团团完成签到,获得积分10
刚刚
追寻的易烟完成签到,获得积分10
刚刚
snow完成签到,获得积分10
1秒前
1秒前
1秒前
1111完成签到,获得积分20
2秒前
爆米花应助笑点低蜜蜂采纳,获得10
2秒前
橘子味汽水完成签到 ,获得积分10
2秒前
Victor陈完成签到,获得积分10
2秒前
2秒前
seed85完成签到,获得积分10
2秒前
最初完成签到,获得积分20
3秒前
Hello应助Chem is try采纳,获得10
3秒前
hhh发布了新的文献求助10
3秒前
3秒前
4秒前
落寞白曼完成签到,获得积分10
5秒前
5秒前
海鸥海鸥发布了新的文献求助10
6秒前
别让我误会完成签到 ,获得积分10
7秒前
7秒前
KK发布了新的文献求助30
7秒前
娃娃完成签到 ,获得积分20
7秒前
科研通AI5应助结实的冰真采纳,获得30
7秒前
冷静的小熊猫完成签到,获得积分10
8秒前
Donnie完成签到,获得积分10
8秒前
若尘完成签到,获得积分10
9秒前
椰子完成签到 ,获得积分10
9秒前
9秒前
细腻涵菱完成签到,获得积分10
10秒前
吕耀炜完成签到,获得积分10
10秒前
10秒前
10秒前
简称王完成签到 ,获得积分10
10秒前
蓝莓松饼完成签到,获得积分10
11秒前
一路高飛完成签到,获得积分10
11秒前
赘婿应助andyxrz采纳,获得10
11秒前
Zhang完成签到,获得积分10
11秒前
12秒前
年轻冥茗完成签到,获得积分10
12秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527304
求助须知:如何正确求助?哪些是违规求助? 3107454
关于积分的说明 9285518
捐赠科研通 2805269
什么是DOI,文献DOI怎么找? 1539827
邀请新用户注册赠送积分活动 716708
科研通“疑难数据库(出版商)”最低求助积分说明 709672